CO logo

Global Cord Blood (CO) Revenue

Annual Revenue

$193.54 M
+$22.38 M+13.08%

March 31, 2022

Summary

Performance

1-Year Change

+13.08%

3-Year Change

+31.57%

5-Year Change

+71.76%

15-Year Change

+71.76%

CO Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$193.54 M
CO annual revenue is currently at an all-time high

3-Year Low

$171.16 M
CO annual revenue is currently +13.08% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Mar 31, 2022
CO previous annual earnings announcement was published on Mar 31, 2022

Next Annual Earnings Report Date

N/A
CO next annual earnings announcement has not yet been scheduled

OtherCOprofitabilitymetrics:

Annual EPS

$0.64
CO annual earnings per share is $0.64

Annual Net Income

$78.00 M
CO annual net profit is $78.00 million

Annual Operating Profit

$94.78 M
CO annual operating income is $94.78 million

Annual Gross Profit

$165.00 M
CO annual gross profit is $165.00 million

Quarterly Revenue

$46.76 M
-$2.81 M-5.67%

March 31, 2022

Summary

Performance

3-Month Change

-5.67%

1-Year Change

+0.35%

3-Year Change

+25.43%

5-Year Change

+59.54%

CO Quarterly Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$49.57 M
CO quarterly revenue is currently -5.67% below its historical high of $49.57 million

3-Year Low

$46.76 M
CO quarterly revenue is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2022
CO previous earnings announcement was published on Mar 31, 2022

Next Quarterly Earnings Report Date

N/A
CO next earnings announcement has not yet been scheduled

Related metrics

Quarterly Gross Profit

$40.15 M
CO quarterly gross profit is $40.15 million

Quarterly Operating Profit

$22.36 M
CO quarterly operating income is $22.36 million

Quarterly Net Income

$16.47 M
CO quarterly net profit is $16.47 million

Quarterly EPS

$0.14
CO quarterly earnings per share is $0.14

TTM Revenue

$193.54 M
+$161.90 K+0.08%

March 31, 2022

Summary

Performance

3-Month Change

+0.08%

1-Year Change

+12.97%

3-Year Change

+14.15%

5-Year Change

+14.15%

CO TTM Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$193.54 M
CO TTM revenue is currently at an all-time high

3-Year Low

$193.38 M
CO TTM revenue is currently +0.08% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2022
CO previous earnings announcement was published on Mar 31, 2022

Next Quarterly Earnings Report Date

N/A
CO next earnings announcement has not yet been scheduled

OtherCOprofitabilitymetrics:

TTM Gross Profit

$165.01 M
CO TTM gross profit is $165.01 million

TTM Operating Profit

$94.76 M
CO TTM operating income is $94.76 million

TTM Net Income

$77.97 M
CO TTM net profit is $77.97 million

TTM EPS

$0.64
CO TTM earnings per share is $0.64

CO Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+13.1%+0.3%+13.0%
3 y3 years+31.6%+25.4%+14.2%
5 y5 years+71.8%+59.5%+14.2%

CO Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high-11.6%-5.7%at lowat high-0.1%
5 y5-yearat high-24.0%-5.7%-15.3%at high-13.4%
alltimeall timeat high-80.2%-5.7%-81.8%at high-95.6%

Global Cord Blood Revenue History

DateAnnualQuarterlyTTM
Mar 2022
$193.54 M(+13.1%)
$46.76 M(-5.7%)
$193.54 M(+0.1%)
Dec 2021
-
$49.57 M(+2.3%)
$193.38 M(+3.0%)
Sep 2021
-
$48.43 M(-0.7%)
$187.67 M(+4.0%)
Jun 2021
-
$48.78 M(+4.7%)
$180.48 M(+5.3%)
Mar 2021
$171.16 M(-2.4%)
$46.60 M(+6.2%)
$171.32 M(+2.2%)
Dec 2020
-
$43.86 M(+6.3%)
$167.68 M(-2.1%)
Sep 2020
-
$41.25 M(+4.1%)
$171.34 M(-2.0%)
Jun 2020
-
$39.62 M(-7.8%)
$174.76 M(-0.3%)
Mar 2020
$175.35 M(+19.2%)
$42.95 M(-9.6%)
$175.22 M(+3.3%)
Dec 2019
-
$47.52 M(+6.4%)
$169.54 M(+6.8%)
Sep 2019
-
$44.68 M(+11.5%)
$158.78 M(+5.6%)
Jun 2019
-
$40.07 M(+7.5%)
$150.41 M(+2.3%)
Mar 2019
$147.10 M(+3.6%)
$37.28 M(+1.4%)
$147.05 M(+0.5%)
Dec 2018
-
$36.76 M(+1.2%)
$146.39 M(-0.2%)
Sep 2018
-
$36.31 M(-1.1%)
$146.68 M(+0.8%)
Jun 2018
-
$36.71 M(+0.3%)
$145.55 M(+2.8%)
Mar 2018
$141.92 M(+25.9%)
$36.62 M(-1.2%)
$141.53 M(+5.4%)
Dec 2017
-
$37.04 M(+5.3%)
$134.22 M(+6.3%)
Sep 2017
-
$35.18 M(+7.6%)
$126.31 M(+6.4%)
Jun 2017
-
$32.69 M(+11.5%)
$118.75 M(+5.5%)
Mar 2017
$112.68 M(+8.1%)
$29.31 M(+0.6%)
$112.53 M(+5.0%)
Dec 2016
-
$29.14 M(+5.5%)
$107.19 M(+2.5%)
Sep 2016
-
$27.62 M(+4.3%)
$104.55 M(+0.4%)
Jun 2016
-
$26.47 M(+10.5%)
$104.14 M(-0.2%)
Mar 2016
$104.26 M
$23.96 M(-9.6%)
$104.32 M(-2.0%)
Dec 2015
-
$26.50 M(-2.6%)
$106.48 M(-0.6%)
DateAnnualQuarterlyTTM
Sep 2015
-
$27.21 M(+2.1%)
$107.08 M(+2.4%)
Jun 2015
-
$26.65 M(+2.0%)
$104.54 M(+2.0%)
Mar 2015
$102.49 M(+9.5%)
$26.13 M(-3.6%)
$102.49 M(+1.2%)
Dec 2014
-
$27.10 M(+9.9%)
$101.27 M(+2.4%)
Sep 2014
-
$24.67 M(+0.3%)
$98.90 M(+1.6%)
Jun 2014
-
$24.60 M(-1.2%)
$97.35 M(+3.9%)
Mar 2014
$93.63 M(+12.0%)
$24.91 M(+0.8%)
$93.66 M(+3.9%)
Dec 2013
-
$24.72 M(+6.9%)
$90.11 M(+0.9%)
Sep 2013
-
$23.12 M(+10.6%)
$89.26 M(+3.4%)
Jun 2013
-
$20.91 M(-2.1%)
$86.33 M(+3.3%)
Mar 2013
$83.56 M(+40.6%)
$21.35 M(-10.6%)
$83.61 M(+7.1%)
Dec 2012
-
$23.88 M(+18.3%)
$78.05 M(+13.0%)
Sep 2012
-
$20.19 M(+11.0%)
$69.07 M(+7.6%)
Jun 2012
-
$18.19 M(+15.2%)
$64.20 M(+8.0%)
Mar 2012
$59.43 M(+17.7%)
$15.79 M(+6.0%)
$59.45 M(+2.5%)
Dec 2011
-
$14.89 M(-2.8%)
$58.02 M(+2.3%)
Sep 2011
-
$15.32 M(+14.0%)
$56.70 M(+5.8%)
Jun 2011
-
$13.44 M(-6.4%)
$53.57 M(+5.8%)
Mar 2011
$50.49 M(+31.7%)
$14.37 M(+5.9%)
$50.62 M(+8.6%)
Dec 2010
-
$13.57 M(+11.3%)
$46.61 M(+8.0%)
Sep 2010
-
$12.19 M(+16.2%)
$43.15 M(+7.0%)
Jun 2010
-
$10.49 M(+1.3%)
$40.32 M(+5.2%)
Mar 2010
$38.32 M
$10.36 M(+2.5%)
$38.32 M(+37.0%)
Dec 2009
-
$10.11 M(+7.9%)
$27.97 M(+56.6%)
Sep 2009
-
$9.37 M(+10.3%)
$17.86 M(+110.3%)
Jun 2009
-
$8.49 M
$8.49 M

FAQ

  • What is Global Cord Blood annual revenue?
  • What is the all time high annual revenue for Global Cord Blood?
  • What is Global Cord Blood annual revenue year-on-year change?
  • What is Global Cord Blood quarterly revenue?
  • What is the all time high quarterly revenue for Global Cord Blood?
  • What is Global Cord Blood quarterly revenue year-on-year change?
  • What is Global Cord Blood TTM revenue?
  • What is the all time high TTM revenue for Global Cord Blood?
  • What is Global Cord Blood TTM revenue year-on-year change?

What is Global Cord Blood annual revenue?

The current annual revenue of CO is $193.54 M

What is the all time high annual revenue for Global Cord Blood?

Global Cord Blood all-time high annual revenue is $193.54 M

What is Global Cord Blood annual revenue year-on-year change?

Over the past year, CO annual revenue has changed by +$22.38 M (+13.08%)

What is Global Cord Blood quarterly revenue?

The current quarterly revenue of CO is $46.76 M

What is the all time high quarterly revenue for Global Cord Blood?

Global Cord Blood all-time high quarterly revenue is $49.57 M

What is Global Cord Blood quarterly revenue year-on-year change?

Over the past year, CO quarterly revenue has changed by +$161.90 K (+0.35%)

What is Global Cord Blood TTM revenue?

The current TTM revenue of CO is $193.54 M

What is the all time high TTM revenue for Global Cord Blood?

Global Cord Blood all-time high TTM revenue is $193.54 M

What is Global Cord Blood TTM revenue year-on-year change?

Over the past year, CO TTM revenue has changed by +$22.22 M (+12.97%)